Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Larimar Therapeutics Inc. buy Quitte

Larimar Therapeutics Inc.
Start price
€37.88
04.10.16 / 50%
Target price
€44.38
31.01.17
Performance (%)
17.14%
End price
€44.38
31.01.17
Summary
This prediction ended on 31.01.17 with a price of €44.38. The BUY prediction by Quitte finished with a performance of 17.14%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Larimar Therapeutics Inc. 5.143% 5.143% -2.128% 5.747%
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

Comments by Quitte for this prediction

In the thread Zafgen Inc. diskutieren
Prediction Buy
Perf. (%) 17.14%
Target price 3.698
Change
Ends at 31.01.17

Macht Anstalten, den Boden zu verlassen

Quitte stimmt am 04.10.2016 dem Buy-Gesamtsentiment mit dem Kursziel 4.5$ zu.

Quitte 
0
Report Share
04.10.16
Prediction Buy
Perf. (%) 17.14%
Target price 3.698
Change
Ends at 31.01.17

(Zielkurs erreicht)

Quitte 
0
Report Share
31.01.17